EGFR pathway subgroups in Chilean colorectal cancer patients, detected by mutational and expression profiles, associated to different clinicopathological features
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EGFR pathway subgroups in Chilean colorectal cancer patients, detected by mutational and expression profiles, associated to different clinicopathological features
Authors
Keywords
-
Journal
TUMOR BIOLOGY
Volume 39, Issue 9, Pages 101042831772451
Publisher
SAGE Publications
Online
2017-09-22
DOI
10.1177/1010428317724517
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer
- (2015) LI-XU YAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Genetic structure characterization of Chileans reflects historical immigration patterns
- (2015) Susana Eyheramendy et al. Nature Communications
- MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1
- (2014) Xin-Ping Huang et al. FEBS Journal
- Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer
- (2014) Francis M. Giardiello et al. GASTROENTEROLOGY
- Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis
- (2014) Peiwei Li et al. GUT
- PTEN mutation, loss of heterozygosity, promoter methylation and expression in colorectal carcinoma: Two hits on the gene?
- (2014) MAJA HÜHNS et al. ONCOLOGY REPORTS
- BRAFV600E Mutation and Its Association with Clinicopathological Features of Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2014) Dong Chen et al. PLoS One
- Mutación del gen KRAS en el cáncer de colon y recto
- (2014) Iván Roa et al. REVISTA MEDICA DE CHILE
- Mutación del gen BRAF en pacientes con cánceres de colon y recto con KRAS no mutado
- (2014) Iván Roa et al. REVISTA MEDICA DE CHILE
- KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers
- (2013) A I Phipps et al. BRITISH JOURNAL OF CANCER
- PIK3CA and PTEN Gene and Exon Mutation-Specific Clinicopathologic and Molecular Associations in Colorectal Cancer
- (2013) F. L. Day et al. CLINICAL CANCER RESEARCH
- Massively Parallel Tumor Multigene Sequencing to Evaluate Response to Panitumumab in a Randomized Phase III Study of Metastatic Colorectal Cancer
- (2013) M. Peeters et al. CLINICAL CANCER RESEARCH
- Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance
- (2013) Teresa Troiani et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell lines
- (2012) Luke B Hesson et al. BIOLOGICAL PROCEDURES ONLINE
- Increasing crude and adjusted mortality rates for colorectal cancer in a developing South American country
- (2012) A. J. Zarate et al. Colorectal Disease
- miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma
- (2012) Yongxia Zheng et al. FEBS LETTERS
- Use of multivariate analysis to suggest a new molecular classification of colorectal cancer
- (2012) Enric Domingo et al. JOURNAL OF PATHOLOGY
- Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing
- (2012) Bojana Djordjevic et al. MODERN PATHOLOGY
- Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
- (2012) Doron Lipson et al. NATURE MEDICINE
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
- (2011) T Yokota et al. BRITISH JOURNAL OF CANCER
- The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
- (2010) A. Fariña-Sarasqueta et al. ANNALS OF ONCOLOGY
- Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data
- (2010) Cecilia Guastadisegni et al. EUROPEAN JOURNAL OF CANCER
- Role of the Serrated Pathway in Colorectal Cancer Pathogenesis
- (2010) Barbara Leggett et al. GASTROENTEROLOGY
- KRAS and BRAF: drug targets and predictive biomarkers
- (2010) Efsevia Vakiani et al. JOURNAL OF PATHOLOGY
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
- (2009) A. Sartore-Bianchi et al. CANCER RESEARCH
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Classification and Correlates in Colorectal Cancer
- (2007) Shuji Ogino et al. JOURNAL OF MOLECULAR DIAGNOSTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now